INDUCTION THERAPY IN RENAL TRANSPLANTATION WITH ANTITHYMOCYTE GLOBULIN AND BASILIXIMAB- A SINGLE CENTRE RETROSPECTIVE STUDY
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2018, Vol 5, Issue 52
Abstract
BACKGROUND Renal transplantation is the best available form of renal replacement therapy. Induction therapy pre-transplant reduces the incidence of graft rejections. We present a retrospective study comparing different induction methods in living donor kidney transplantation in our institute. MATERIALS AND METHODS We analysed 423 live kidney transplant recipients of our center from Dec 2010 to Nov 2015, 344 of whom received basiliximab as induction and 79 r-ATG as induction. Primary outcomes like patient survival and graft survival, secondary outcomes like graft rejections, infections, PTDM, recurrence of disease were compared. RESULTS 5yr patient survival rates were observed to be 91% and 88% respectively whereas graft survival rates were 93% and 86% respectively for ATG and basiliximab. Incidence of rejections was similar (p=0.867). Cellular rejections were more common with basiliximab (7.9% vs. 3.8%) but statistically not significant (P=0.498). Infections in the post-operative period were more common in r-ATG arm especially LRTI (P=0.011) and diarrhoeal episodes (P=0.005). Incidence of cytopenias was more in rATG arm during hospital stay (10.1 vs. 2.6% P=0.002) and also the later followup period (25 vs. 12.4% P<0.001). Incidence of PTDM was more in basiliximab (33.8% vs. 22.8%) arm but not significant (P=0.061). CONCLUSION ATG and basiliximab are non-inferior to one another as induction therapy. ATG is effective in high immunological risk groups with equivalent graft and patient survival with increased risk of Lower respiratory tract infections and diarrhoea in immediate post-transplant periods and increased risk for cytopenias compared to basiliximab. Basiliximab has slightly increased risk of post-transplant diabetes mellitus. Careful selection of the agent in an individual based on risk rather than a question of efficacy of agents is the key to successful transplantation.
Authors and Affiliations
Hareesh M. V. K, Sharma R. K.
Keywords
Related Articles
- EP ID EP608444
- DOI 10.18410/jebmh/2018/723
- Views 84
- Downloads 0
OCULAR MANIFESTATIONS AND SAFETY AWARENESS AMONG QUARRY WORKERS IN PUDUCHERRY
BACKGROUND The study aims to determine the prevalence of ocular manifestations in quarry workers in Puducherry. Quarry workers are at high risk of developing pterygium, dry eye, ocular injuries, scleral pigmentation, non...
MODIFIED BOYTCHEV PROCEDURE IS AN EFFECTIVE SURGICAL TREATMENT FOR RECCURRENT ANTERIOR DISLOCATION OF SHOULDER
Recurrent anterior dislocation of shoulder is a common orthopedic problem. The pathology is well known i.e. bank arts lesion, hill sachs lesion and capsular laxity. In the literature more than 150 types of surgeries were...
PERCEIVED MET & UNMET NEEDS OF PATIENTS UNDERWENT ARTHROSCOPIC ACL RECONSTRUCTION DONE BY ARTHROSCOPIST ON HIS AND ON BEHALF OF OTHER ORTHOPAEDIC SURGEON AS SHADOW SURGEON
Undergoing surgery is a very stressful experience. Orthopaedic emergency surgeries are different from elective surgeries, patients have ample time to understand the surgical procedure and their expectations are high sinc...
SERUM LIPID CONCENTRATIONS IN PRE-ECLAMPSIA AND NORMAL PREGNANCY - A COMPARATIVE STUDY
The association between pre-eclampsia and atherosclerosis is a much discussed topic. The changes in lipid profile observed during pregnancy have significant effects on woman’s long term health, because elevated serum tri...
SERUM HOMOCYSTEINE AS A RISK FACTOR IN ISCHAEMIC STROKE- A CROSS-SECTIONAL OBSERVATIONAL STUDY IN A TERTIARY CARE TEACHING HOSPITAL IN NORTHERN KERALA
BACKGROUND Stroke is a clinically-defined syndrome of rapidly developing symptoms or signs of focal loss of cerebral function with no apparent cause other than that of vascular origin. A previously unrecognised risk fact...